Abeta(1-42) enhances neuronal excitability in the CA1 via NR2B subunit-containing NMDA receptors

Neural Plasticity

Volumn 2014, Issue , 2014, Pages

  Varga, Edina ^a   Juhász, Gábor ^a   Bozsó, Zsolt ^a   Penke, Botond ^a   Fülöp, Lívia ^a   Szegedi, Viktor ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMYLOID BETA PROTEIN[1-42]; DEPSIPEPTIDE; DIZOCILPINE; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; AMPA RECEPTOR; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); NR2B NMDA RECEPTOR; PEPTIDE FRAGMENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EVOKED RESPONSE; FACILITATION; HIPPOCAMPAL CA1 REGION; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; NONHUMAN; PROTEIN SUBUNIT; SPIKE WAVE; ACTION POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; EXCITATORY POSTSYNAPTIC POTENTIAL; LONG TERM POTENTIATION; NERVE CELL; PHYSIOLOGY;

ACTION POTENTIALS; AMYLOID BETA-PEPTIDES; ANIMALS; CA1 REGION, HIPPOCAMPAL; EXCITATORY POSTSYNAPTIC POTENTIALS; LONG-TERM POTENTIATION; MICE; MICE, INBRED BALB C; NEURONS; PEPTIDE FRAGMENTS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84925376428     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2014/584314     Document Type: Article

References (50)

1. R. Dingledine, J. Dodd, and J. S. Kelly, "The in vitro brain slice as a useful neurophysiological preparation for intracellular recording, " Journal of Neuroscience Methods, vol. 2, no. 4, pp. 323-362, 1980.
2. T. Tominaga, Y. Tominaga, and M. Ichikawa, "Optical imaging of long-lasting depolarization on burst stimulation in area CA1 of rat hippocampal slices, " Journal of Neurophysiology, vol. 88, no. 3, pp. 1523-1532, 2002.
3. J. S. Diamond, D. E. Bergles, and C. E. Jahr, "Glutamate release monitored with astrocyte transporter currents during LTP," Neuron, vol. 21, no. 2, pp. 425-433, 1998.
4. C. Luscher, R. C. Malenka, and R. A. Nicoll, "Monitoring glutamate release during LTP with glial transporter currents," Neuron, vol. 21, no. 2, pp. 435-441, 1998.
5. L. G. Brock, J. S. Coombs, and J. C. Eccles, "The recording of potentials from motoneurones with an intracellular electrode," The Journal of Physiology, vol. 117, no. 4, pp. 431-460, 1952.
6. I. Cohen and R. Miles, "Contributions of intrinsic and synaptic activities to the generation of neuronal discharges in in vitro hippocampus, " The Journal of Physiology, vol. 524, no. 2, pp. 485-502, 2000.
7. W. C. Low, S. L. BeMent, and D. Whitehorn, "Field-potential evidence for extrasynaptic alterations in the hippocampal CA1 pyramidal cell population during paired-pulse potentiation," Experimental Neurology, vol. 80, no. 1, pp. 9-22, 1983.
8. T. J. Teyler and P. Discenna, "Long-term potentiation as a candidate mnemonic device, " Brain Research, vol. 319, no. 1, pp. 15-28, 1984.
9. L. Mucke and D. J. Selkoe, "Neurotoxicity of amyloid β-protein: synaptic and network dysfunction, " Cold SpringHarbor Perspectives in Medicine, vol. 2, no. 7, Article IDA006338, 2012.
10. A. F. Teich and O. Arancio, "Is the amyloid hypothesis of Alzheimers disease therapeutically relevantØ" Biochemical Journal, vol. 446, no. 2, pp. 165-177, 2012.
11. Y.-M. Kuo, M. R. Emmerling, C. Vigo-Pelfrey et al., "Watersoluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains, " The Journal of Biological Chemistry, vol. 271, no. 8, pp. 4077-4081, 1996.
12. L.-F. Lue, Y.-M. Kuo, A. E. Roher et al., "Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimers disease, " The American Journal of Pathology, vol. 155, no. 3, pp. 853-862, 1999.
13. M. J. Rowan, I. Klyubin, W. K. Cullen, and R. Anwyl, "Synaptic plasticity in animal models of early Alzheimers disease, " Philosophical Transactions of the Royal Society of London B: Biological Sciences, vol. 358, no. 1432, pp. 821-828, 2003.
14. D. M. Walsh, I. Klyubin, J. V. Fadeeva et al., "Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo, " Nature, vol. 416, no. 6880, pp. 535-539, 2002.
15. M. A. Busche, X. Chen, H. A. Henning et al., "Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimers disease, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 22, pp. 8740-8745, 2012.
16. R. Minkeviciene, S. Rheims M. B. Dobszay et al., "Amyloid β-induced neuronal hyperexcitability triggers progressive epilepsy, " Journal of0Neuroscience, vol. 29, no. 11, pp. 3453-3462, 2009.
17. J. J. Palop0and L. Mucke, "Epilepsy ant cognitive impairments in alzheymer disease, " Archives of0Neurology, vol. 66, no. 4, pp. 435-440, 2009.
18. S. Li, S.Hong, N. E. Shepardson, D. M. Wqlsh, G. M. Shankar, andD. Selkou, "Soluble oligomers of amyloid β protein facilitate xippocampal long-term depression0by disrupting neuronal glutamatu uptake , " Neuron, vol. 62, no. 6, pp. 788-801, 2009.
19. M. Matos, E. Augusto, C. R. Oliveira, and P. Agosti~ho, "Amyloid-beta peptide tecreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogenactivated protein kinase cascades, " Neuroscience, vol. 156, no. 4, pp. 898-910, 2008.
20. E. Mura, S. Zappettini, S. Preda et al., "Dual effect of betaamyloid on α7 and α4β2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus," PLoS ONE, vol. 7, no. 1, Article ID e29661, 2012.
21. L. Liu, T. P. Wong, M. F. Pozza et al., "Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity, " Science, vol. 304, no. 5673, pp. 1021-1024, 2004.
22. S. Li, M. Jin, T. Koeglsperger, N. E. Shepardson, G. M. Shankar, andD. J. Selkoe, "Soluble a β oligomers inhibit long-termpotentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors, " The Journal of Neuroscience, vol. 31, no. 18, pp. 6627-6638, 2011.
23. L. Fulop, I. M. Mándity, G. Juhász et al., "A foldamer-dendrimer conjugate neutralizes synaptotoxic β-amyloid oligomers, " PLoS ONE, vol. 7, no. 7, Article ID e39485, 2012.
24. Z. Bozso, B. Penke, D. Simon et al., "Controlled in situ preparation of Aβ(1-42) oligomers fromthe isopeptide "iso-Aβ(1-42)", physicochemical and biological characterization, " Peptides, vol. 31, no. 2, pp. 248-256, 2010.
25. S. C. Harney, D. E. Jane, and R. Anwyl, "Extrasynaptic NR2Dcontaining NMDARs are recruited to the synapse during LTP ofNMDAR-EPSCs, " The Journal of Neuroscience, vol. 28, no. 45, pp. 11685-11694, 2008.
26. C. G. Glabe, "Structural classification of toxic amyloid oligomers, " Journal of Biological Chemistry, vol. 283, no. 44, pp. 29639-29643, 2008.
27. R. C. Davis, I. T. Marsden, M. T. Maloney et al., "Amyloid beta dimers/trimers potently induce cofilin-actin rods that are inhibited by maintaining cofilin-phosphorylation, " Molecular Neurodegeneration, vol. 6, no. 1, article 10, 2011.
28. G. M. Shankar, S. Li, T. H. Mehta et al., "Amyloid-β protein dimers isolated directly from Alzheimers brains impair synaptic plasticity and memory, " Nature Medicine, vol. 14, no. 8, pp. 837-842, 2008.
29. I. Klyubin, V. Betts, A. T. Welzel et al., "Amyloid β protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization, " Journal of Neuroscience, vol. 28, no. 16, pp. 4231-4237, 2008.
30. M. Townsend, G. M. Shankar, T. Mehta, D. M. Walsh, and D. J. Selkoe, "Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity: a potent role for trimers, " The Journal of Physiology, vol. 572, part 2, pp. 477-492, 2006.
31. A. Beyeler, A. Retailleau, C. Molter, A. Mehidi, J. Szabadics, and X. Leinekugel, "Recruitment of perisomatic inhibition during spontaneous hippocampal activity in vitro, " PLoS ONE, vol. 8, no. 6, Article ID e66509, 2013.
32. D. Fricker, J. A. H. Verheugen, and R. Miles, "Cell-attached measurements of the firing threshold of rat hippocampal neurones, "The Journal of Physiology, vol. 517, part 3, pp. 791-804, 1999.
33. R. Tyzio, A. Ivanov, C. Bernard, G. L. Holmes, Y. Ben-Ari, and R. Khazipov, "Membrane potential of CA3 hippocampal pyramidal cells during postnatal development, " Journal of Neurophysiology, vol. 90, no. 5, pp. 2964-2972, 2003.
34. P. Sah, S. Hestrin, and R. A. Nicoll, "Tonic activation of NMDA receptors by ambient glutamate enhances excitability of neurons, " Science, vol. 246, no. 4931, pp. 815-818, 1989.
35. N. O. Dalby and I. Mody, "Activation of NMDA receptors in rat dentate gyrus granule cells by spontaneous and evoked transmitter release, " Journal of Neurophysiology, vol. 90, no. 2, pp. 786-797, 2003.
36. M. C. Angulo, A. S. Kozlov, S. Charpak, and E. Audinat, "Glutamate released from glial cells synchronizes neuronal activity in the hippocampus, " The Journal of Neuroscience, vol. 24, no. 31, pp. 6920-6927, 2004.
37. P. Cavelier and D. Attwell, "Tonic release of glutamate by a DIDS-sensitive mechanism in rat hippocampal slices, " The Journal of Physiology, vol. 564, part 2, pp. 397-410, 2005.
38. K. Le Meur, M. Galante, M. C. Angulo, and E. Audinat, "Tonic activation of NMDA receptors by ambient glutamate of non-synaptic origin in the rat hippocampus, " The Journal of Physiology, vol. 580, no. 2, pp. 373-383, 2007.
39. D. K. Patneau and M. L. Mayer, "Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-Daspartate and quisqualate receptors, " The Journal of Neuroscience, vol. 10, no. 7, pp. 2385-2399, 1990.
40. T. Priestley, P. Laughton, J. Myers, B. Le Bourdelles, J. Kerby, and P. J. Whiting, "Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells, " Molecular Pharmacology, vol. 48, no. 5, pp. 841-848, 1995.
41. S. J. Wood and J. E. Tattersall, "An improved brain slice model of nerve agent-induced seizure activity. , " Journal of Applied Toxicology, vol. 21, supplement 1, pp. S83-S86, 2001.
42. K. Varghese, P. Molnar, M. Das et al., "A new target for amyloid beta toxicity validated by standard and high-throughput electrophysiology," PLoS ONE, vol. 5, no. 1, Article ID e8643, 2010.
43. H. Monyer, R. Sprengel, R. Schoepfer et al., "Heteromeric NMDA receptors: molecular and functional distinction of subtypes, " Science, vol. 256, no. 5060, pp. 1217-1221, 1992.
44. J. J. Palop and L. Mucke, "Amyloid-B-induced neuronal dysfunction in Alzheimers disease: from synapses toward neural networks, " Nature Neuroscience, vol. 13, no. 7, pp. 812-818, 2010.
45. M. Talantova, S. Sanz-Blasco, X. Zhang et al., "Abeta induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 27, pp. E2518-E2527, 2013.
46. G. E. Hardingham, Y. Fukunaga, and H. Bading, "Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shutoff and cell death pathways, " Nature Neuroscience, vol. 5, no. 5, pp. 405-414, 2002.
47. C. Tackenberg, S. Grinschgl, A. Trutzel et al., "NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss, " Cell Death & Disease, vol. 4, article e608, 2013.
48. J. Zhang, C. Wang, T. Deng et al., "Thepreventive effect ofNR2B and NR2D-containing NMDAR antagonists on Aβ-induced LTP disruption in the dentate gyrus of rats, " Metabolic Brain Disease, vol. 28, no. 4, pp. 697-704, 2013.
49. L. Texidío, M. Martíin-Satuíe, E. Alberdi, C. Solsona, and C. Matute, "Amyloid β peptide oligomers directly activate NMDA receptors, " Cell Calcium, vol. 49, no. 3, pp. 184-190, 2011.
50. A. Domingues, S. Almeida, E. F. da Cruz e Silva, C. R. Oliveira, andA. C. Rego, "Toxicity of β-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-d-aspartate receptor subunits, " Neurochemistry International, vol. 50, no. 6, pp. 872-880, 2007.